DrugPatentWatch Database Preview
Details for Patent: 8,252,776
Try a free trial
See Plans and Pricing
Which drugs does patent 8,252,776 protect, and when does it expire?
Patent 8,252,776 protects XIMINO and SOLODYN and is included in two NDAs.
This patent has thirteen patent family members in ten countries.
Summary for Patent: 8,252,776
| Title: | Minocycline oral dosage forms for the treatment of acne |
| Abstract: | Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne. |
| Inventor(s): | Wortzman; Mitchell (Scottsdale, AZ), Plott; R. Todd (Briscoe, TX), Bhatia; Kuljit (Nesconset, NY), Patel; Bhiku (Chandler, AZ) |
| Assignee: | Medicis Pharmaceutical Corporation (Scottsdale, AZ) |
| Application Number: | 11/695,513 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,252,776 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; Composition; |
Drugs Protected by US Patent 8,252,776
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-001 | Jul 11, 2012 | RX | No | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF ACNE | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-003 | Jul 11, 2012 | RX | No | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF ACNE | ➤ Sign Up | ||||
| Sun Pharm Inds Ltd | XIMINO | minocycline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 201922-005 | Jul 11, 2012 | RX | No | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF ACNE | ➤ Sign Up | ||||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-001 | May 8, 2006 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF ACNE | ➤ Sign Up | ||||
| Medicis | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-008 | Aug 27, 2010 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF ACNE | ➤ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,252,776
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006262428 | ➤ Sign Up | |||
| Canada | 2613273 | ➤ Sign Up | |||
| China | 101208097 | ➤ Sign Up | |||
| European Patent Office | 1898925 | ➤ Sign Up | |||
| Israel | 188331 | ➤ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
